nodes	percent_of_prediction	percent_of_DWPC	metapath
Quetiapine—HTR2C—metabolic syndrome X	0.597	1	CbGaD
Quetiapine—Seasonal allergy—Metformin—metabolic syndrome X	0.0106	0.0722	CcSEcCtD
Quetiapine—Rhinitis seasonal—Metformin—metabolic syndrome X	0.0102	0.0693	CcSEcCtD
Quetiapine—Viral diarrhoea—Metformin—metabolic syndrome X	0.00853	0.058	CcSEcCtD
Quetiapine—Sinus headache—Metformin—metabolic syndrome X	0.00683	0.0464	CcSEcCtD
Quetiapine—HTR7—sympathetic nervous system—metabolic syndrome X	0.00683	0.0847	CbGeAlD
Quetiapine—HTR2A—arteriole—metabolic syndrome X	0.00669	0.0829	CbGeAlD
Quetiapine—Tooth abscess—Metformin—metabolic syndrome X	0.00533	0.0362	CcSEcCtD
Quetiapine—HTR7—autonomic nervous system—metabolic syndrome X	0.00459	0.0569	CbGeAlD
Quetiapine—Sinus congestion—Metformin—metabolic syndrome X	0.00448	0.0304	CcSEcCtD
Quetiapine—HTR2A—sympathetic nervous system—metabolic syndrome X	0.00426	0.0528	CbGeAlD
Quetiapine—Hypothermia—Metformin—metabolic syndrome X	0.00397	0.027	CcSEcCtD
Quetiapine—Body temperature decreased—Metformin—metabolic syndrome X	0.00397	0.027	CcSEcCtD
Quetiapine—Toothache—Metformin—metabolic syndrome X	0.00366	0.0249	CcSEcCtD
Quetiapine—Upset stomach—Metformin—metabolic syndrome X	0.0034	0.0231	CcSEcCtD
Quetiapine—HTR1B—artery—metabolic syndrome X	0.00338	0.0418	CbGeAlD
Quetiapine—HTR1D—artery—metabolic syndrome X	0.00327	0.0405	CbGeAlD
Quetiapine—HTR2A—autonomic nervous system—metabolic syndrome X	0.00286	0.0355	CbGeAlD
Quetiapine—Blood disorder—Metformin—metabolic syndrome X	0.00267	0.0181	CcSEcCtD
Quetiapine—HTR1B—blood vessel—metabolic syndrome X	0.00263	0.0326	CbGeAlD
Quetiapine—HTR7—artery—metabolic syndrome X	0.0026	0.0323	CbGeAlD
Quetiapine—Contusion—Metformin—metabolic syndrome X	0.00255	0.0173	CcSEcCtD
Quetiapine—HTR1D—blood vessel—metabolic syndrome X	0.00255	0.0316	CbGeAlD
Quetiapine—Accidental injury—Metformin—metabolic syndrome X	0.00252	0.0171	CcSEcCtD
Quetiapine—Olanzapine—FMO3—metabolic syndrome X	0.00221	0.245	CrCbGaD
Quetiapine—HTR7—endothelium—metabolic syndrome X	0.0022	0.0273	CbGeAlD
Quetiapine—HTR7—blood vessel—metabolic syndrome X	0.00203	0.0251	CbGeAlD
Quetiapine—Ear pain—Metformin—metabolic syndrome X	0.00189	0.0129	CcSEcCtD
Quetiapine—Nasal congestion—Metformin—metabolic syndrome X	0.00177	0.0121	CcSEcCtD
Quetiapine—Injury—Metformin—metabolic syndrome X	0.00176	0.0119	CcSEcCtD
Quetiapine—Hypoglycaemia—Metformin—metabolic syndrome X	0.00166	0.0113	CcSEcCtD
Quetiapine—Lethargy—Metformin—metabolic syndrome X	0.00165	0.0112	CcSEcCtD
Quetiapine—HTR2A—artery—metabolic syndrome X	0.00162	0.0201	CbGeAlD
Quetiapine—Pain in extremity—Metformin—metabolic syndrome X	0.00162	0.011	CcSEcCtD
Quetiapine—Migraine—Metformin—metabolic syndrome X	0.00159	0.0108	CcSEcCtD
Quetiapine—ADRA1B—kidney—metabolic syndrome X	0.00152	0.0188	CbGeAlD
Quetiapine—Dehydration—Metformin—metabolic syndrome X	0.0015	0.0102	CcSEcCtD
Quetiapine—Abdominal pain upper—Metformin—metabolic syndrome X	0.00148	0.01	CcSEcCtD
Quetiapine—H1F0—cardiovascular system—metabolic syndrome X	0.00147	0.0182	CbGeAlD
Quetiapine—Breast disorder—Metformin—metabolic syndrome X	0.00146	0.00992	CcSEcCtD
Quetiapine—Cramp muscle—Metformin—metabolic syndrome X	0.00146	0.00989	CcSEcCtD
Quetiapine—Nasopharyngitis—Metformin—metabolic syndrome X	0.00145	0.00982	CcSEcCtD
Quetiapine—H1F0—kidney—metabolic syndrome X	0.00143	0.0178	CbGeAlD
Quetiapine—Abdominal distension—Metformin—metabolic syndrome X	0.00141	0.00955	CcSEcCtD
Quetiapine—Influenza—Metformin—metabolic syndrome X	0.0014	0.00949	CcSEcCtD
Quetiapine—HTR2A—endothelium—metabolic syndrome X	0.00137	0.017	CbGeAlD
Quetiapine—Pancreatitis—Metformin—metabolic syndrome X	0.00137	0.0093	CcSEcCtD
Quetiapine—Angina pectoris—Metformin—metabolic syndrome X	0.00136	0.00924	CcSEcCtD
Quetiapine—Abdominal discomfort—Metformin—metabolic syndrome X	0.00134	0.0091	CcSEcCtD
Quetiapine—Neutropenia—Metformin—metabolic syndrome X	0.00131	0.00887	CcSEcCtD
Quetiapine—Upper respiratory tract infection—Metformin—metabolic syndrome X	0.0013	0.00882	CcSEcCtD
Quetiapine—H1F0—adipose tissue—metabolic syndrome X	0.00129	0.016	CbGeAlD
Quetiapine—HTR2A—blood vessel—metabolic syndrome X	0.00127	0.0157	CbGeAlD
Quetiapine—Infestation NOS—Metformin—metabolic syndrome X	0.00125	0.00846	CcSEcCtD
Quetiapine—Infestation—Metformin—metabolic syndrome X	0.00125	0.00846	CcSEcCtD
Quetiapine—CYP3A7—liver—metabolic syndrome X	0.00122	0.0152	CbGeAlD
Quetiapine—Hepatobiliary disease—Metformin—metabolic syndrome X	0.00118	0.008	CcSEcCtD
Quetiapine—HTR1B—cardiovascular system—metabolic syndrome X	0.00117	0.0145	CbGeAlD
Quetiapine—CHRM2—cardiovascular system—metabolic syndrome X	0.00117	0.0145	CbGeAlD
Quetiapine—Clozapine—FMO3—metabolic syndrome X	0.00115	0.128	CrCbGaD
Quetiapine—Bradycardia—Metformin—metabolic syndrome X	0.00114	0.00773	CcSEcCtD
Quetiapine—HTR1D—cardiovascular system—metabolic syndrome X	0.00114	0.0141	CbGeAlD
Quetiapine—Rhinitis—Metformin—metabolic syndrome X	0.00112	0.00762	CcSEcCtD
Quetiapine—Hepatitis—Metformin—metabolic syndrome X	0.00112	0.0076	CcSEcCtD
Quetiapine—Hypoaesthesia—Metformin—metabolic syndrome X	0.00111	0.00756	CcSEcCtD
Quetiapine—HTR1D—kidney—metabolic syndrome X	0.00111	0.0138	CbGeAlD
Quetiapine—Oedema peripheral—Metformin—metabolic syndrome X	0.0011	0.00748	CcSEcCtD
Quetiapine—Connective tissue disorder—Metformin—metabolic syndrome X	0.0011	0.00746	CcSEcCtD
Quetiapine—CHRM1—cardiovascular system—metabolic syndrome X	0.00106	0.0132	CbGeAlD
Quetiapine—Eye disorder—Metformin—metabolic syndrome X	0.00105	0.0071	CcSEcCtD
Quetiapine—CYP3A7-CYP3A51P—liver—metabolic syndrome X	0.00104	0.0129	CbGeAlD
Quetiapine—Cardiac disorder—Metformin—metabolic syndrome X	0.00104	0.00705	CcSEcCtD
Quetiapine—Angiopathy—Metformin—metabolic syndrome X	0.00101	0.00689	CcSEcCtD
Quetiapine—Immune system disorder—Metformin—metabolic syndrome X	0.00101	0.00686	CcSEcCtD
Quetiapine—Mediastinal disorder—Metformin—metabolic syndrome X	0.00101	0.00685	CcSEcCtD
Quetiapine—Chills—Metformin—metabolic syndrome X	0.001	0.00682	CcSEcCtD
Quetiapine—Malnutrition—Metformin—metabolic syndrome X	0.000973	0.00661	CcSEcCtD
Quetiapine—Flatulence—Metformin—metabolic syndrome X	0.000959	0.00652	CcSEcCtD
Quetiapine—Dysgeusia—Metformin—metabolic syndrome X	0.000953	0.00648	CcSEcCtD
Quetiapine—HTR1A—cardiovascular system—metabolic syndrome X	0.000947	0.0117	CbGeAlD
Quetiapine—Muscle spasms—Metformin—metabolic syndrome X	0.000936	0.00636	CcSEcCtD
Quetiapine—CHRM3—kidney—metabolic syndrome X	0.00093	0.0115	CbGeAlD
Quetiapine—Vision blurred—Metformin—metabolic syndrome X	0.000917	0.00623	CcSEcCtD
Quetiapine—Tremor—Metformin—metabolic syndrome X	0.000912	0.0062	CcSEcCtD
Quetiapine—H1F0—liver—metabolic syndrome X	0.000907	0.0112	CbGeAlD
Quetiapine—HTR7—cardiovascular system—metabolic syndrome X	0.000905	0.0112	CbGeAlD
Quetiapine—Ill-defined disorder—Metformin—metabolic syndrome X	0.000903	0.00614	CcSEcCtD
Quetiapine—HTR7—kidney—metabolic syndrome X	0.000885	0.011	CbGeAlD
Quetiapine—Malaise—Metformin—metabolic syndrome X	0.000878	0.00596	CcSEcCtD
Quetiapine—Syncope—Metformin—metabolic syndrome X	0.000873	0.00593	CcSEcCtD
Quetiapine—ADRA1A—cardiovascular system—metabolic syndrome X	0.000873	0.0108	CbGeAlD
Quetiapine—Palpitations—Metformin—metabolic syndrome X	0.00086	0.00584	CcSEcCtD
Quetiapine—Loss of consciousness—Metformin—metabolic syndrome X	0.000856	0.00581	CcSEcCtD
Quetiapine—Hypertension—Metformin—metabolic syndrome X	0.00084	0.00571	CcSEcCtD
Quetiapine—CHRM3—adipose tissue—metabolic syndrome X	0.000838	0.0104	CbGeAlD
Quetiapine—ABCB1—blood vessel—metabolic syndrome X	0.000829	0.0103	CbGeAlD
Quetiapine—Myalgia—Metformin—metabolic syndrome X	0.000829	0.00563	CcSEcCtD
Quetiapine—Chest pain—Metformin—metabolic syndrome X	0.000829	0.00563	CcSEcCtD
Quetiapine—Unspecified disorder of skin and subcutaneous tissue—Metformin—metabolic syndrome X	0.000823	0.00559	CcSEcCtD
Quetiapine—Discomfort—Metformin—metabolic syndrome X	0.000819	0.00556	CcSEcCtD
Quetiapine—ADRA2C—kidney—metabolic syndrome X	0.000814	0.0101	CbGeAlD
Quetiapine—Infection—Metformin—metabolic syndrome X	0.000789	0.00536	CcSEcCtD
Quetiapine—Shock—Metformin—metabolic syndrome X	0.000782	0.00531	CcSEcCtD
Quetiapine—Nervous system disorder—Metformin—metabolic syndrome X	0.000779	0.00529	CcSEcCtD
Quetiapine—Thrombocytopenia—Metformin—metabolic syndrome X	0.000778	0.00528	CcSEcCtD
Quetiapine—Skin disorder—Metformin—metabolic syndrome X	0.000772	0.00524	CcSEcCtD
Quetiapine—ADRA1A—adipose tissue—metabolic syndrome X	0.00077	0.00954	CbGeAlD
Quetiapine—Hyperhidrosis—Metformin—metabolic syndrome X	0.000768	0.00522	CcSEcCtD
Quetiapine—Anorexia—Metformin—metabolic syndrome X	0.000757	0.00514	CcSEcCtD
Quetiapine—Hypotension—Metformin—metabolic syndrome X	0.000742	0.00504	CcSEcCtD
Quetiapine—ADRA2C—adipose tissue—metabolic syndrome X	0.000733	0.00909	CbGeAlD
Quetiapine—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.000724	0.00492	CcSEcCtD
Quetiapine—Paraesthesia—Metformin—metabolic syndrome X	0.000713	0.00485	CcSEcCtD
Quetiapine—Dyspnoea—Metformin—metabolic syndrome X	0.000708	0.00481	CcSEcCtD
Quetiapine—Somnolence—Metformin—metabolic syndrome X	0.000706	0.0048	CcSEcCtD
Quetiapine—Dyspepsia—Metformin—metabolic syndrome X	0.000699	0.00475	CcSEcCtD
Quetiapine—Decreased appetite—Metformin—metabolic syndrome X	0.000691	0.00469	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.000686	0.00466	CcSEcCtD
Quetiapine—Fatigue—Metformin—metabolic syndrome X	0.000685	0.00465	CcSEcCtD
Quetiapine—CYP3A5—kidney—metabolic syndrome X	0.000681	0.00844	CbGeAlD
Quetiapine—Constipation—Metformin—metabolic syndrome X	0.000679	0.00462	CcSEcCtD
Quetiapine—Feeling abnormal—Metformin—metabolic syndrome X	0.000655	0.00445	CcSEcCtD
Quetiapine—Gastrointestinal pain—Metformin—metabolic syndrome X	0.00065	0.00441	CcSEcCtD
Quetiapine—Abdominal pain—Metformin—metabolic syndrome X	0.000628	0.00427	CcSEcCtD
Quetiapine—Metixene—HTR2C—metabolic syndrome X	0.000626	0.0695	CrCbGaD
Quetiapine—CYP3A5—adipose tissue—metabolic syndrome X	0.000614	0.00761	CbGeAlD
Quetiapine—HRH1—adipose tissue—metabolic syndrome X	0.000596	0.00738	CbGeAlD
Quetiapine—ADRA2A—adipose tissue—metabolic syndrome X	0.000585	0.00725	CbGeAlD
Quetiapine—Asthenia—Metformin—metabolic syndrome X	0.00057	0.00387	CcSEcCtD
Quetiapine—HTR2A—cardiovascular system—metabolic syndrome X	0.000564	0.00699	CbGeAlD
Quetiapine—Pruritus—Metformin—metabolic syndrome X	0.000562	0.00382	CcSEcCtD
Quetiapine—HTR7—liver—metabolic syndrome X	0.00056	0.00694	CbGeAlD
Quetiapine—HTR2A—kidney—metabolic syndrome X	0.000552	0.00684	CbGeAlD
Quetiapine—CYP2C19—liver—metabolic syndrome X	0.000547	0.00677	CbGeAlD
Quetiapine—Diarrhoea—Metformin—metabolic syndrome X	0.000544	0.00369	CcSEcCtD
Quetiapine—ADRA1A—liver—metabolic syndrome X	0.00054	0.00669	CbGeAlD
Quetiapine—Dizziness—Metformin—metabolic syndrome X	0.000525	0.00357	CcSEcCtD
Quetiapine—ADRA2C—liver—metabolic syndrome X	0.000514	0.00638	CbGeAlD
Quetiapine—CYP3A4—kidney—metabolic syndrome X	0.000511	0.00634	CbGeAlD
Quetiapine—Vomiting—Metformin—metabolic syndrome X	0.000505	0.00343	CcSEcCtD
Quetiapine—CYP2D6—kidney—metabolic syndrome X	0.000503	0.00623	CbGeAlD
Quetiapine—Rash—Metformin—metabolic syndrome X	0.000501	0.0034	CcSEcCtD
Quetiapine—Dermatitis—Metformin—metabolic syndrome X	0.0005	0.0034	CcSEcCtD
Quetiapine—Headache—Metformin—metabolic syndrome X	0.000498	0.00338	CcSEcCtD
Quetiapine—Nefazodone—HTR2C—metabolic syndrome X	0.00048	0.0533	CrCbGaD
Quetiapine—Nausea—Metformin—metabolic syndrome X	0.000472	0.00321	CcSEcCtD
Quetiapine—Olanzapine—HTR2C—metabolic syndrome X	0.000459	0.051	CrCbGaD
Quetiapine—Trazodone—HTR2C—metabolic syndrome X	0.000444	0.0493	CrCbGaD
Quetiapine—CYP3A5—liver—metabolic syndrome X	0.000431	0.00534	CbGeAlD
Quetiapine—Thiothixene—HTR2C—metabolic syndrome X	0.000416	0.0462	CrCbGaD
Quetiapine—Prochlorperazine—HTR2C—metabolic syndrome X	0.000397	0.0441	CrCbGaD
Quetiapine—ABCB1—cardiovascular system—metabolic syndrome X	0.00037	0.00458	CbGeAlD
Quetiapine—Amoxapine—HTR2C—metabolic syndrome X	0.000366	0.0406	CrCbGaD
Quetiapine—ABCB1—kidney—metabolic syndrome X	0.000362	0.00448	CbGeAlD
Quetiapine—Fluphenazine—HTR2C—metabolic syndrome X	0.000359	0.0399	CrCbGaD
Quetiapine—HTR2A—liver—metabolic syndrome X	0.000349	0.00433	CbGeAlD
Quetiapine—ABCB1—adipose tissue—metabolic syndrome X	0.000326	0.00404	CbGeAlD
Quetiapine—CYP3A4—liver—metabolic syndrome X	0.000323	0.004	CbGeAlD
Quetiapine—CYP2D6—liver—metabolic syndrome X	0.000318	0.00394	CbGeAlD
Quetiapine—Trifluoperazine—HTR2C—metabolic syndrome X	0.000287	0.0319	CrCbGaD
Quetiapine—Loxapine—HTR2C—metabolic syndrome X	0.000286	0.0317	CrCbGaD
Quetiapine—Perphenazine—HTR2C—metabolic syndrome X	0.000284	0.0316	CrCbGaD
Quetiapine—Promazine—HTR2C—metabolic syndrome X	0.000256	0.0285	CrCbGaD
Quetiapine—Clozapine—HTR2C—metabolic syndrome X	0.00024	0.0266	CrCbGaD
Quetiapine—ABCB1—liver—metabolic syndrome X	0.000229	0.00283	CbGeAlD
Quetiapine—Olanzapine—ALB—metabolic syndrome X	0.0002	0.0222	CrCbGaD
Quetiapine—Thioproperazine—ALB—metabolic syndrome X	0.000184	0.0205	CrCbGaD
Quetiapine—Pipotiazine—ALB—metabolic syndrome X	0.000181	0.0201	CrCbGaD
Quetiapine—Thiothixene—ALB—metabolic syndrome X	0.000181	0.0201	CrCbGaD
Quetiapine—CHRM3—Metabolism—NOS3—metabolic syndrome X	8.55e-06	5.15e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—IRS1—metabolic syndrome X	8.54e-06	5.15e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling by GPCR—AKT1—metabolic syndrome X	8.53e-06	5.14e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—APOB—metabolic syndrome X	8.53e-06	5.14e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—IRS1—metabolic syndrome X	8.51e-06	5.13e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—SERPINE1—metabolic syndrome X	8.46e-06	5.1e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—IRS1—metabolic syndrome X	8.43e-06	5.08e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—CETP—metabolic syndrome X	8.41e-06	5.07e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—CD36—metabolic syndrome X	8.41e-06	5.07e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—IRS1—metabolic syndrome X	8.41e-06	5.07e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling by GPCR—AKT1—metabolic syndrome X	8.39e-06	5.06e-05	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—PPARG—metabolic syndrome X	8.36e-06	5.04e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—INS—metabolic syndrome X	8.36e-06	5.04e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—NOS3—metabolic syndrome X	8.35e-06	5.03e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—SERPINE1—metabolic syndrome X	8.33e-06	5.02e-05	CbGpPWpGaD
Quetiapine—DRD1—GPCR downstream signaling—AKT1—metabolic syndrome X	8.32e-06	5.01e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—NOS3—metabolic syndrome X	8.3e-06	5e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PLA2G4A—metabolic syndrome X	8.29e-06	5e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling by GPCR—AKT1—metabolic syndrome X	8.28e-06	4.99e-05	CbGpPWpGaD
Quetiapine—HTR1E—Signaling Pathways—IL6—metabolic syndrome X	8.22e-06	4.96e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—INS—metabolic syndrome X	8.22e-06	4.96e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—CCL2—metabolic syndrome X	8.22e-06	4.96e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—CD36—metabolic syndrome X	8.21e-06	4.95e-05	CbGpPWpGaD
Quetiapine—DRD3—GPCR downstream signaling—AKT1—metabolic syndrome X	8.21e-06	4.95e-05	CbGpPWpGaD
Quetiapine—ADRA1D—GPCR downstream signaling—AKT1—metabolic syndrome X	8.21e-06	4.95e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—INS—metabolic syndrome X	8.2e-06	4.94e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—ALB—metabolic syndrome X	8.2e-06	4.94e-05	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—INS—metabolic syndrome X	8.2e-06	4.94e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling by GPCR—IL6—metabolic syndrome X	8.19e-06	4.93e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—INS—metabolic syndrome X	8.18e-06	4.93e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—INS—metabolic syndrome X	8.15e-06	4.91e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—LPL—metabolic syndrome X	8.14e-06	4.91e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—CCL2—metabolic syndrome X	8.09e-06	4.88e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—IGF1—metabolic syndrome X	8.08e-06	4.87e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling by GPCR—IL6—metabolic syndrome X	8.08e-06	4.87e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling by GPCR—IL6—metabolic syndrome X	8.08e-06	4.87e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—NOS3—metabolic syndrome X	8.08e-06	4.87e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—INS—metabolic syndrome X	8.07e-06	4.87e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—CCL2—metabolic syndrome X	8.07e-06	4.87e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—SCARB1—metabolic syndrome X	8.06e-06	4.86e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—INS—metabolic syndrome X	8.05e-06	4.85e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—CCL2—metabolic syndrome X	8.05e-06	4.85e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—CCL2—metabolic syndrome X	8.02e-06	4.83e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—IGF1—metabolic syndrome X	7.95e-06	4.79e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—NOS3—metabolic syndrome X	7.95e-06	4.79e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—CCL2—metabolic syndrome X	7.94e-06	4.79e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—IGF1—metabolic syndrome X	7.94e-06	4.78e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling by GPCR—AKT1—metabolic syndrome X	7.93e-06	4.78e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—CCL2—metabolic syndrome X	7.92e-06	4.77e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—IGF1—metabolic syndrome X	7.91e-06	4.77e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—IGF1—metabolic syndrome X	7.89e-06	4.75e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—NOS3—metabolic syndrome X	7.84e-06	4.73e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—SREBF1—metabolic syndrome X	7.82e-06	4.71e-05	CbGpPWpGaD
Quetiapine—CHRM3—Metabolism—PTGS2—metabolic syndrome X	7.82e-06	4.71e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—PPARA—metabolic syndrome X	7.82e-06	4.71e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—IRS1—metabolic syndrome X	7.81e-06	4.71e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—IGF1—metabolic syndrome X	7.81e-06	4.71e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—IGF1—metabolic syndrome X	7.79e-06	4.69e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—CD36—metabolic syndrome X	7.73e-06	4.66e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—SERPINE1—metabolic syndrome X	7.68e-06	4.63e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—PPARA—metabolic syndrome X	7.63e-06	4.6e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—GOT2—metabolic syndrome X	7.61e-06	4.59e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—HMGCR—metabolic syndrome X	7.61e-06	4.59e-05	CbGpPWpGaD
Quetiapine—HTR1E—Signaling Pathways—AKT1—metabolic syndrome X	7.59e-06	4.57e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—AGT—metabolic syndrome X	7.57e-06	4.56e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling by GPCR—AKT1—metabolic syndrome X	7.55e-06	4.55e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—SERPINE1—metabolic syndrome X	7.55e-06	4.55e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—SERPINE1—metabolic syndrome X	7.54e-06	4.54e-05	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—ALB—metabolic syndrome X	7.52e-06	4.53e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—SERPINE1—metabolic syndrome X	7.51e-06	4.53e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—SERPINE1—metabolic syndrome X	7.49e-06	4.51e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—INS—metabolic syndrome X	7.48e-06	4.51e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—TGFB1—metabolic syndrome X	7.46e-06	4.49e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling by GPCR—AKT1—metabolic syndrome X	7.45e-06	4.49e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling by GPCR—AKT1—metabolic syndrome X	7.45e-06	4.49e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—TGFB1—metabolic syndrome X	7.45e-06	4.49e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—APOE—metabolic syndrome X	7.42e-06	4.47e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—SERPINE1—metabolic syndrome X	7.42e-06	4.47e-05	CbGpPWpGaD
Quetiapine—ADRA2B—GPCR downstream signaling—AKT1—metabolic syndrome X	7.41e-06	4.47e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—TGFB1—metabolic syndrome X	7.4e-06	4.46e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—SERPINE1—metabolic syndrome X	7.39e-06	4.46e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—AGT—metabolic syndrome X	7.39e-06	4.45e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—CCL2—metabolic syndrome X	7.36e-06	4.44e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—APOA1—metabolic syndrome X	7.33e-06	4.42e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—NOS3—metabolic syndrome X	7.33e-06	4.42e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling by GPCR—IL6—metabolic syndrome X	7.29e-06	4.4e-05	CbGpPWpGaD
Quetiapine—DRD5—Signaling Pathways—IL6—metabolic syndrome X	7.28e-06	4.39e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—TGFB1—metabolic syndrome X	7.24e-06	4.37e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—APOE—metabolic syndrome X	7.24e-06	4.36e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—IGF1—metabolic syndrome X	7.24e-06	4.36e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—NOS3—metabolic syndrome X	7.21e-06	4.35e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—NOS3—metabolic syndrome X	7.19e-06	4.34e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PPARA—metabolic syndrome X	7.19e-06	4.33e-05	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—NOS3—metabolic syndrome X	7.19e-06	4.33e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—PTGS2—metabolic syndrome X	7.18e-06	4.32e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—NOS3—metabolic syndrome X	7.17e-06	4.32e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—APOA1—metabolic syndrome X	7.16e-06	4.31e-05	CbGpPWpGaD
Quetiapine—HTR1A—GPCR downstream signaling—AKT1—metabolic syndrome X	7.15e-06	4.31e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—NOS3—metabolic syndrome X	7.15e-06	4.31e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—TGFB1—metabolic syndrome X	7.13e-06	4.3e-05	CbGpPWpGaD
Quetiapine—HTR2C—GPCR downstream signaling—AKT1—metabolic syndrome X	7.11e-06	4.29e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—NOS3—metabolic syndrome X	7.08e-06	4.27e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—NOS3—metabolic syndrome X	7.06e-06	4.26e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling by GPCR—IL6—metabolic syndrome X	7.04e-06	4.24e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—TGFB1—metabolic syndrome X	7.03e-06	4.24e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling by GPCR—IL6—metabolic syndrome X	7e-06	4.22e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—AGT—metabolic syndrome X	6.96e-06	4.2e-05	CbGpPWpGaD
Quetiapine—ADRA2C—GPCR downstream signaling—AKT1—metabolic syndrome X	6.92e-06	4.17e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—SERPINE1—metabolic syndrome X	6.87e-06	4.14e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—APOE—metabolic syndrome X	6.82e-06	4.11e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling by GPCR—IL6—metabolic syndrome X	6.81e-06	4.11e-05	CbGpPWpGaD
Quetiapine—ADRA1B—GPCR downstream signaling—AKT1—metabolic syndrome X	6.81e-06	4.1e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—ABCA1—metabolic syndrome X	6.78e-06	4.09e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—SLC2A4—metabolic syndrome X	6.78e-06	4.09e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—APOA1—metabolic syndrome X	6.75e-06	4.07e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—TGFB1—metabolic syndrome X	6.74e-06	4.06e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling by GPCR—AKT1—metabolic syndrome X	6.73e-06	4.05e-05	CbGpPWpGaD
Quetiapine—DRD5—Signaling Pathways—AKT1—metabolic syndrome X	6.71e-06	4.05e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling by GPCR—IL6—metabolic syndrome X	6.7e-06	4.04e-05	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—PTGS2—metabolic syndrome X	6.58e-06	3.96e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—GGT1—metabolic syndrome X	6.57e-06	3.96e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—GOT1—metabolic syndrome X	6.57e-06	3.96e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—NOS3—metabolic syndrome X	6.56e-06	3.95e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling by GPCR—AKT1—metabolic syndrome X	6.49e-06	3.91e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—PPARG—metabolic syndrome X	6.46e-06	3.89e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling by GPCR—AKT1—metabolic syndrome X	6.46e-06	3.89e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—TGFB1—metabolic syndrome X	6.42e-06	3.87e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—INS—metabolic syndrome X	6.34e-06	3.82e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—TGFB1—metabolic syndrome X	6.33e-06	3.82e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—TGFB1—metabolic syndrome X	6.33e-06	3.82e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—PPARG—metabolic syndrome X	6.31e-06	3.8e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling by GPCR—AKT1—metabolic syndrome X	6.28e-06	3.79e-05	CbGpPWpGaD
Quetiapine—DRD2—GPCR downstream signaling—AKT1—metabolic syndrome X	6.28e-06	3.78e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—INS—metabolic syndrome X	6.19e-06	3.73e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling by GPCR—AKT1—metabolic syndrome X	6.18e-06	3.73e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling by GPCR—IL6—metabolic syndrome X	6.18e-06	3.73e-05	CbGpPWpGaD
Quetiapine—HTR2A—GPCR downstream signaling—AKT1—metabolic syndrome X	6.18e-06	3.72e-05	CbGpPWpGaD
Quetiapine—HRH1—GPCR downstream signaling—AKT1—metabolic syndrome X	6.17e-06	3.72e-05	CbGpPWpGaD
Quetiapine—CHRM1—GPCR downstream signaling—AKT1—metabolic syndrome X	6.15e-06	3.7e-05	CbGpPWpGaD
Quetiapine—CHRM3—GPCR downstream signaling—AKT1—metabolic syndrome X	6.13e-06	3.69e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling by GPCR—IL6—metabolic syndrome X	6.08e-06	3.67e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling by GPCR—IL6—metabolic syndrome X	6.07e-06	3.66e-05	CbGpPWpGaD
Quetiapine—CHRM2—GPCR downstream signaling—AKT1—metabolic syndrome X	6.07e-06	3.66e-05	CbGpPWpGaD
Quetiapine—ADRA1A—GPCR downstream signaling—AKT1—metabolic syndrome X	6.05e-06	3.65e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling by GPCR—IL6—metabolic syndrome X	6.05e-06	3.65e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling by GPCR—IL6—metabolic syndrome X	6.03e-06	3.63e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling by GPCR—IL6—metabolic syndrome X	5.97e-06	3.6e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling by GPCR—IL6—metabolic syndrome X	5.95e-06	3.59e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PPARG—metabolic syndrome X	5.94e-06	3.58e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—INS—metabolic syndrome X	5.83e-06	3.51e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—ALB—metabolic syndrome X	5.81e-06	3.5e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—TGFB1—metabolic syndrome X	5.72e-06	3.45e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling by GPCR—AKT1—metabolic syndrome X	5.7e-06	3.44e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—ALB—metabolic syndrome X	5.67e-06	3.42e-05	CbGpPWpGaD
Quetiapine—ADRA2A—GPCR downstream signaling—AKT1—metabolic syndrome X	5.62e-06	3.39e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—IL6—metabolic syndrome X	5.62e-06	3.39e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—IL6—metabolic syndrome X	5.61e-06	3.38e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling by GPCR—AKT1—metabolic syndrome X	5.61e-06	3.38e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling by GPCR—AKT1—metabolic syndrome X	5.6e-06	3.37e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling by GPCR—AKT1—metabolic syndrome X	5.58e-06	3.36e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—IL6—metabolic syndrome X	5.58e-06	3.36e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—APOB—metabolic syndrome X	5.57e-06	3.36e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling by GPCR—AKT1—metabolic syndrome X	5.56e-06	3.35e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—NOS3—metabolic syndrome X	5.56e-06	3.35e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—IL6—metabolic syndrome X	5.53e-06	3.33e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—TGFB1—metabolic syndrome X	5.52e-06	3.33e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling by GPCR—AKT1—metabolic syndrome X	5.51e-06	3.32e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling by GPCR—AKT1—metabolic syndrome X	5.49e-06	3.31e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—TGFB1—metabolic syndrome X	5.49e-06	3.31e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—IL6—metabolic syndrome X	5.46e-06	3.29e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—NOS3—metabolic syndrome X	5.42e-06	3.27e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PLA2G4A—metabolic syndrome X	5.42e-06	3.27e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—IL6—metabolic syndrome X	5.37e-06	3.24e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—ALB—metabolic syndrome X	5.34e-06	3.22e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—TGFB1—metabolic syndrome X	5.34e-06	3.22e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—LPL—metabolic syndrome X	5.32e-06	3.21e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—IL6—metabolic syndrome X	5.3e-06	3.19e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—TGFB1—metabolic syndrome X	5.26e-06	3.17e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—AKT1—metabolic syndrome X	5.18e-06	3.12e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—AKT1—metabolic syndrome X	5.18e-06	3.12e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—AKT1—metabolic syndrome X	5.14e-06	3.1e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—NOS3—metabolic syndrome X	5.11e-06	3.08e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—AKT1—metabolic syndrome X	5.1e-06	3.08e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—PTGS2—metabolic syndrome X	5.08e-06	3.06e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—IL6—metabolic syndrome X	5.08e-06	3.06e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—CD36—metabolic syndrome X	5.06e-06	3.05e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—AKT1—metabolic syndrome X	5.04e-06	3.04e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—PTGS2—metabolic syndrome X	4.96e-06	2.99e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—AKT1—metabolic syndrome X	4.96e-06	2.99e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—AKT1—metabolic syndrome X	4.89e-06	2.95e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—TGFB1—metabolic syndrome X	4.85e-06	2.92e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—IL6—metabolic syndrome X	4.84e-06	2.91e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—IL6—metabolic syndrome X	4.77e-06	2.88e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—IL6—metabolic syndrome X	4.77e-06	2.88e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—TGFB1—metabolic syndrome X	4.77e-06	2.87e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—TGFB1—metabolic syndrome X	4.76e-06	2.87e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—TGFB1—metabolic syndrome X	4.74e-06	2.86e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—TGFB1—metabolic syndrome X	4.73e-06	2.85e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PPARA—metabolic syndrome X	4.7e-06	2.83e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—AKT1—metabolic syndrome X	4.68e-06	2.82e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—TGFB1—metabolic syndrome X	4.68e-06	2.82e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PTGS2—metabolic syndrome X	4.68e-06	2.82e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—TGFB1—metabolic syndrome X	4.67e-06	2.81e-05	CbGpPWpGaD
Quetiapine—CYP3A7—Metabolism—AKT1—metabolic syndrome X	4.57e-06	2.76e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—AGT—metabolic syndrome X	4.55e-06	2.74e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—AKT1—metabolic syndrome X	4.46e-06	2.69e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—APOE—metabolic syndrome X	4.46e-06	2.69e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Metabolism—AKT1—metabolic syndrome X	4.44e-06	2.68e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—APOA1—metabolic syndrome X	4.41e-06	2.66e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—AKT1—metabolic syndrome X	4.4e-06	2.65e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—AKT1—metabolic syndrome X	4.4e-06	2.65e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—TGFB1—metabolic syndrome X	4.34e-06	2.61e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—IL6—metabolic syndrome X	4.31e-06	2.6e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—IL6—metabolic syndrome X	4.16e-06	2.51e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—IL6—metabolic syndrome X	4.14e-06	2.49e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—IL6—metabolic syndrome X	4.02e-06	2.43e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—AKT1—metabolic syndrome X	3.97e-06	2.4e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—IL6—metabolic syndrome X	3.96e-06	2.39e-05	CbGpPWpGaD
Quetiapine—CHRM3—Metabolism—AKT1—metabolic syndrome X	3.93e-06	2.37e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PPARG—metabolic syndrome X	3.89e-06	2.34e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—AKT1—metabolic syndrome X	3.84e-06	2.31e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—AKT1—metabolic syndrome X	3.82e-06	2.3e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—INS—metabolic syndrome X	3.81e-06	2.3e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—AKT1—metabolic syndrome X	3.71e-06	2.24e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—AKT1—metabolic syndrome X	3.65e-06	2.2e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—IL6—metabolic syndrome X	3.65e-06	2.2e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—AKT1—metabolic syndrome X	3.61e-06	2.17e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—IL6—metabolic syndrome X	3.59e-06	2.17e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—IL6—metabolic syndrome X	3.58e-06	2.16e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—IL6—metabolic syndrome X	3.57e-06	2.15e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—IL6—metabolic syndrome X	3.56e-06	2.15e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—IL6—metabolic syndrome X	3.53e-06	2.13e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—IL6—metabolic syndrome X	3.52e-06	2.12e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—ALB—metabolic syndrome X	3.49e-06	2.11e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—AKT1—metabolic syndrome X	3.37e-06	2.03e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—NOS3—metabolic syndrome X	3.34e-06	2.01e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—AKT1—metabolic syndrome X	3.31e-06	2e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—AKT1—metabolic syndrome X	3.31e-06	1.99e-05	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—AKT1—metabolic syndrome X	3.3e-06	1.99e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—AKT1—metabolic syndrome X	3.3e-06	1.99e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—AKT1—metabolic syndrome X	3.29e-06	1.98e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—IL6—metabolic syndrome X	3.27e-06	1.97e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—AKT1—metabolic syndrome X	3.25e-06	1.96e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—AKT1—metabolic syndrome X	3.25e-06	1.96e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PTGS2—metabolic syndrome X	3.06e-06	1.84e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—AKT1—metabolic syndrome X	3.02e-06	1.82e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—AKT1—metabolic syndrome X	2.55e-06	1.54e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—AKT1—metabolic syndrome X	2.49e-06	1.5e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—AKT1—metabolic syndrome X	2.35e-06	1.42e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—AKT1—metabolic syndrome X	1.54e-06	9.26e-06	CbGpPWpGaD
